CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 133 filers reported holding CTI BIOPHARMA CORP in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,526,632 | -76.2% | 601,579 | -83.8% | 1.04% | -31.3% |
| Q4 2022 | $10,637,000 | -8.9% | 3,702,651 | -15.6% | 1.51% | -41.2% |
| Q3 2022 | $11,681,000 | -19.3% | 4,389,546 | -20.0% | 2.57% | +56.3% |
| Q2 2022 | $14,470,000 | -43.6% | 5,489,546 | 0.0% | 1.65% | -72.3% |
| Q1 2022 | $25,636,000 | +745.0% | 5,489,546 | +348.6% | 5.95% | +631.7% |
| Q4 2021 | $3,034,000 | – | 1,223,595 | – | 0.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|